The attached technical alert contains details of the revisions to the permitted indication list, details around requesting an extension if desired, and the proposed implementation including future applications for indications.

CMA has made the following submission regarding intentional omissions or changes to the existing Listed medicine system. CMA did not repeat general indication requests made by individual members as the TGA has provided that each submission would be fully assessed and repetition would slow down the process.

Biomarker / biological substrates

Maternal health and infancy

Traditional qualifiers

Mild and Medically Diagnosed including BPH, etc.